Current trends on resveratrol bioactivities to treat periodontitis

[1]  C. Giuliani,et al.  Lavandula dentata from Italy: Analysis of Trichomes and Volatiles , 2020, Chemistry & biodiversity.

[2]  P. Keim,et al.  Differential Thermotolerance Adaptation between Species of Coccidioides , 2020, bioRxiv.

[3]  Bin Bao,et al.  Resveratrol and Celastrol Loaded Collagen Dental Implants Regulate Periodontal Ligament Fibroblast Growth and Osteoclastogenesis of Bone Marrow Macrophages , 2020, Chemistry & biodiversity.

[4]  C. F. Rodrigues,et al.  Candida spp./Bacteria Mixed Biofilms , 2019, Journal of fungi.

[5]  Bingren Tian,et al.  Resveratrol:A review of plant sources, synthesis, stability, modification and food application. , 2019, Journal of the science of food and agriculture.

[6]  A. T. Lau,et al.  Phytofabrication of Nanoparticles as Novel Drugs for Anticancer Applications , 2019, Molecules.

[7]  G. Russo,et al.  Mechanisms of aging and potential role of selected polyphenols in extending healthspan. , 2019, Biochemical pharmacology.

[8]  M. Diederich,et al.  Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology. , 2019, European journal of medicinal chemistry.

[9]  Mohadeseh Aghasi,et al.  The Effects of Resveratrol on Oxidative Stress Markers: A Systematic Review and Meta-Analysis on Randomized Clinical Trials. , 2019, Endocrine, metabolic & immune disorders drug targets.

[10]  Chen Chen,et al.  Effects and Mechanisms of Traditional Chinese Herbal Medicine in the Treatment of Ischemic Cardiomyopathy. , 2019, Pharmacological research.

[11]  V. Cuomo,et al.  The Heme Oxygenase/Biliverdin Reductase System as Effector of the Neuroprotective Outcomes of Herb-Based Nutritional Supplements , 2019, Front. Pharmacol..

[12]  Jian-Guo Jiang,et al.  Antidepressant active ingredients from herbs and nutraceuticals used in TCM: pharmacological mechanisms and prospects for drug discovery. , 2019, Pharmacological research.

[13]  C. Selvam,et al.  Molecular Mechanisms of Curcumin and Its Analogs in Colon Cancer Prevention and Treatment. , 2019, Life sciences.

[14]  S. Carradori,et al.  Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases , 2019, Archiv der Pharmazie.

[15]  T. P. Ong,et al.  Bioactive food compounds, epigenetics and chronic disease prevention: Focus on early-life interventions with polyphenols. , 2019, Food research international.

[16]  F. Ajayi,et al.  A Unique Formulation of Cardioprotective Bio-Actives: An Overview of Their Safety Profile , 2019, Medicines.

[17]  M. Najafi,et al.  Resveratrol as an adjuvant for normal tissues protection and tumor sensitization. , 2019, Current cancer drug targets.

[18]  L. Cai,et al.  Resveratrol As A Natural Regulator Of Autophagy For Prevention And Treatment Of Cancer , 2019, OncoTargets and therapy.

[19]  S. Siddharth,et al.  Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer , 2019, Cancers.

[20]  Wuwen Feng,et al.  Natural medicines for the treatment of fatigue: Bioactive components, pharmacology, and mechanisms. , 2019, Pharmacological research.

[21]  U. Wazir,et al.  Chemoprevention of Prostate Cancer by Natural Agents: Evidence from Molecular and Epidemiological Studies , 2019, AntiCancer Research.

[22]  Xue-jun Cui,et al.  Neurological recovery and antioxidant effects of resveratrol in rats with spinal cord injury: a meta-analysis , 2019, Neural regeneration research.

[23]  P. Sharma,et al.  Phytochemicals based chemopreventive and chemotherapeutic strategies and modern technologies to overcome limitations for better clinical applications , 2019, Phytotherapy research : PTR.

[24]  Da-Hye Son,et al.  Recent Advances in Anti-Aging Medicine , 2019, Korean journal of family medicine.

[25]  D. Chartoumpekis,et al.  A Bibliometric Review of the Keap1/Nrf2 Pathway and its Related Antioxidant Compounds , 2019, Antioxidants.

[26]  M. Farzaei,et al.  Promising plant-derived secondary metabolites for treatment of acne vulgaris: a mechanistic review , 2019, Archives of Dermatological Research.

[27]  M. Valko,et al.  Management of oxidative stress and other pathologies in Alzheimer’s disease , 2019, Archives of Toxicology.

[28]  J. González-Hernández,et al.  Resveratrol cytotoxicity is energy-dependent. , 2019, Journal of food biochemistry.

[29]  R. Malla,et al.  A Review on the Effect of Plant Extract on Mesenchymal Stem Cell Proliferation and Differentiation , 2019, Stem cells international.

[30]  F. Biagioni,et al.  Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism , 2019, International journal of molecular sciences.

[31]  K. Nowomiejska,et al.  Effect of Resveratrol on In Vitro and In Vivo Models of Diabetic Retinophathy: A Systematic Review , 2019, International journal of molecular sciences.

[32]  M. Farzaei,et al.  Nanoformulations of natural products for management of metabolic syndrome , 2019, International journal of nanomedicine.

[33]  O. Franco,et al.  Dietary Factors and Modulation of Bacteria Strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: A Systematic Review , 2019, Nutrients.

[34]  R. Taheri,et al.  Phytochemicals as Modulators of Long Non-Coding RNAs and Inhibitors of Cancer-Related Carbonic Anhydrases , 2019, International journal of molecular sciences.

[35]  D. Grenier,et al.  Resveratrol attenuates the pathogenic and inflammatory properties of Porphyromonas gingivalis. , 2019, Molecular oral microbiology.

[36]  K. M. Rahman,et al.  Antibiotic resistance breakers: current approaches and future directions , 2019, FEMS microbiology reviews.

[37]  K. Bhat,et al.  Effect of Resveratrol on biofilm formation and virulence factor gene expression of Porphyromonas gingivalis in periodontal disease , 2019, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[38]  I. Casaburi,et al.  Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol , 2019, International journal of molecular sciences.

[39]  S. Moco,et al.  Resveratrol and Its Human Metabolites—Effects on Metabolic Health and Obesity , 2019, Nutrients.

[40]  E. Georgousopoulou,et al.  The Effects of Dietary Polyphenols on Circulating Cardiovascular Disease Biomarkers and Iron Status: A Systematic Review , 2019, Nutrition and metabolic insights.

[41]  C. Steves,et al.  Genetic and environmental contributions to the association between mood disorder and periodontal disease: A cross‐sectional study among female twins in the UK , 2018, Journal of clinical periodontology.

[42]  R. Lamuela-Raventós,et al.  Health Effects of Resveratrol: Results from Human Intervention Trials , 2018, Nutrients.

[43]  S. Kunsági-Máté,et al.  Interactions of casticin, ipriflavone, and resveratrol with serum albumin and their inhibitory effects on CYP2C9 and CYP3A4 enzymes. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[44]  Hojjat Allah Abbaszadeh,et al.  Resveratrol: A miraculous natural compound for diseases treatment , 2018, Food science & nutrition.

[45]  M. G. Corrêa,et al.  Resveratrol attenuates oxidative stress during experimental periodontitis in rats exposed to cigarette smoke inhalation , 2018, Journal of periodontal research.

[46]  Hongmei Liu,et al.  Periodontal ligament‐associated protein‐1 gets involved in experimental periodontitis , 2018, Journal of periodontal research.

[47]  Wei Wang,et al.  Antibiotic resistance: a rundown of a global crisis , 2018, Infection and drug resistance.

[48]  A. Mishra,et al.  Resveratrol: A Double-Edged Sword in Health Benefits , 2018, Biomedicines.

[49]  S. Sut,et al.  Supplementation with resveratrol as Polygonum cuspidatum Sieb. et Zucc. extract induces changes in the excretion of urinary markers associated to aging in rats. , 2018, Fitoterapia.

[50]  K. Hatori,et al.  Expression of silent information regulator 2 homolog 1 (SIRT1) in periapical granulomas. , 2018, Journal of oral science.

[51]  K. Hatori,et al.  A potential role for the silent information regulator 2 homologue 1 (SIRT1) in periapical periodontitis , 2018, International endodontic journal.

[52]  J. Ebersole,et al.  Dietary Polyphenols and Periodontitis—A Mini-Review of Literature , 2018, Molecules.

[53]  Howard C. Tenenbaum,et al.  Resveratrol derivative‐rich melinjo seed extract induces healing in a murine model of established periodontitis , 2018, Journal of periodontology.

[54]  T. Okui,et al.  Resveratrol suppresses the alveolar bone resorption induced by artificial trauma from occlusion in mice. , 2018, Oral diseases.

[55]  Xiaomeng Sun,et al.  Protective effects of resveratrol improve cardiovascular function in rats with diabetes. , 2017, Experimental and therapeutic medicine.

[56]  P. Papapanou,et al.  Periodontitis epidemiology: is periodontitis under-recognized, over-diagnosed, or both? , 2017, Periodontology 2000.

[57]  M. Holz,et al.  The therapeutic potential of resveratrol: a review of clinical trials , 2017, npj Precision Oncology.

[58]  E. Ioannidou.  The Sex and Gender Intersection in Chronic Periodontitis , 2017, Front. Public Health.

[59]  J. Davies,et al.  Resveratrol Inhibits Periodontitis‐Related Bone Loss in Rats Subjected to Cigarette Smoke Inhalation , 2017, The Journal of Periodontology.

[60]  S. Mammi,et al.  Studying the effects of natural extracts with metabolomics: A longitudinal study on the supplementation of healthy rats with Polygonum cuspidatum Sieb. et Zucc. , 2017, Journal of pharmaceutical and biomedical analysis.

[61]  D. Yee,et al.  Revisiting the IGF-1R as a breast cancer target , 2017, npj Precision Oncology.

[62]  M. G. Corrêa,et al.  Systemic treatment with resveratrol and/or curcumin reduces the progression of experimental periodontitis in rats , 2017, Journal of periodontal research.

[63]  Wim Teughels,et al.  Interaction of lifestyle, behaviour or systemic diseases with dental caries and periodontal diseases: consensus report of group 2 of the joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases , 2017, Journal of clinical periodontology.

[64]  Praveen Sharma,et al.  Global epidemiology of dental caries and severe periodontitis – a comprehensive review , 2017, Journal of clinical periodontology.

[65]  J. Gribben,et al.  Chronic lymphocytic leukaemia , 2015, Radiopaedia.org.

[66]  Hanhong Bae,et al.  An Overview of Stress-Induced Resveratrol Synthesis in Grapes: Perspectives for Resveratrol-Enriched Grape Products , 2017, Molecules.

[67]  Jessica A. Martinez,et al.  Effects of resveratrol on drug‐ and carcinogen‐metabolizing enzymes, implications for cancer prevention , 2017, Pharmacology research & perspectives.

[68]  Rabita Jahan,et al.  Sirtuin 1 regulates matrix metalloproteinase-13 expression induced by Porphyromonas endodontalis lipopolysaccharide via targeting nuclear factor–κB in osteoblasts , 2017, Journal of oral microbiology.

[69]  G. Wang,et al.  Resveratrol-induced antinociception is involved in calcium channels and calcium/caffeine-sensitive pools , 2016, Oncotarget.

[70]  F. V. Ribeiro,et al.  Effect of Resveratrol on periodontal pathogens during experimental periodontitis in rats. , 2016, Brazilian oral research.

[71]  P. Schrauwen,et al.  Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial , 2016, Diabetes Care.

[72]  K. Umegaki,et al.  Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse Model , 2016, Journal of atherosclerosis and thrombosis.

[73]  Huijun Sun,et al.  P-gp, MRP2 and OAT1/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate. , 2016, Toxicology and applied pharmacology.

[74]  D. Dai,et al.  The effect of resveratrol on pharmacokinetics of aripiprazole in vivo and in vitro , 2016, Xenobiotica; the fate of foreign compounds in biological systems.

[75]  K. Tabeta,et al.  Resveratrol suppresses the inflammatory responses of human gingival epithelial cells in a SIRT1 independent manner. , 2015, Journal of periodontal research.

[76]  M. Trevisan,et al.  Elicitation and accumulation of stilbene phytoalexins in grapevine berries infected by Botrytis cinerea , 2015 .

[77]  J. Viña,et al.  Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans , 2015, Oxidative medicine and cellular longevity.

[78]  N. Ahmad,et al.  Resveratrol and cancer: Challenges for clinical translation. , 2015, Biochimica et biophysica acta.

[79]  P. Eke,et al.  Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. , 2015, Journal of periodontology.

[80]  M. Casati,et al.  Current perspective of the impact of smoking on the progression and treatment of periodontitis. , 2015, Periodontology 2000.

[81]  M. Portillo,et al.  Resveratrol: Anti-Obesity Mechanisms of Action , 2014, Molecules.

[82]  C. Murray,et al.  Global Burden of Severe Periodontitis in 1990-2010 , 2014, Journal of dental research.

[83]  J. Pratten,et al.  Development of an in vitro periodontal biofilm model for assessing antimicrobial and host modulatory effects of bioactive molecules , 2014, BMC oral health.

[84]  C. Susin,et al.  Epidemiology and demographics of aggressive periodontitis. , 2014, Periodontology 2000.

[85]  Luciana Mosca,et al.  Chemistry, stability and bioavailability of resveratrol. , 2014, Medicinal chemistry (Shariqah (United Arab Emirates)).

[86]  B. Holtfreter,et al.  Prediction of periodontal disease: modelling and validation in different general German populations. , 2014, Journal of clinical periodontology.

[87]  D. Colombo,et al.  Cyclosporine and Herbal Supplement Interactions , 2014, Journal of toxicology.

[88]  Postolache,et al.  Role of chronic stress and depression in periodontal diseases , 2014, BDJ.

[89]  S. Ottonello,et al.  Anti-estrogenic activity of a human resveratrol metabolite. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[90]  F. V. Ribeiro,et al.  Resveratrol decreases periodontal breakdown and modulates local levels of cytokines during periodontitis in rats. , 2013, Journal of periodontology.

[91]  L. Jasińska,et al.  Resveratrol in prostate diseases – a short review , 2013, Central European journal of urology.

[92]  G. Park,et al.  Effects of sirtuin 1 activation on nicotine and lipopolysaccharide-induced cytotoxicity and inflammatory cytokine production in human gingival fibroblasts. , 2013, Journal of periodontal research.

[93]  Liu Wenying,et al.  A simple method for the isolation and purification of resveratrol from Polygonum cuspidatum. , 2013 .

[94]  Q. Mei,et al.  Comparision of Piceid and Resveratrol in Antioxidation and Antiproliferation Activities In Vitro , 2013, PloS one.

[95]  Guang-tong Chen,et al.  A simple method for the isolation and purification of resveratrol from Polygonum cuspidatum , 2012, Journal of pharmaceutical analysis.

[96]  S. Krähenbühl,et al.  Drug interaction potential of resveratrol , 2012, Drug metabolism reviews.

[97]  R. Zechner,et al.  Resveratrol regulates lipolysis via adipose triglyceride lipase. , 2012, The Journal of nutritional biochemistry.

[98]  A. Neves,et al.  Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. , 2012, Current medicinal chemistry.

[99]  E-C Kim,et al.  The role of sirtuin 1 in osteoblastic differentiation in human periodontal ligament cells. , 2011, Journal of periodontal research.

[100]  M. Savio,et al.  Structure-activity relationship of resveratrol and its analogue, 4,4'-dihydroxy-trans-stilbene, toward the endothelin axis in human endothelial cells. , 2011, Journal of medicinal food.

[101]  H. Mukhtar,et al.  Enhancing the bioavailability of resveratrol by combining it with piperine. , 2011, Molecular nutrition & food research.

[102]  Karen Brown,et al.  Clinical trials of resveratrol , 2011, Annals of the New York Academy of Sciences.

[103]  F. Ghiringhelli,et al.  Transport, stability, and biological activity of resveratrol , 2011, Annals of the New York Academy of Sciences.

[104]  Jessica A. Miller,et al.  Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study , 2010, Cancer Prevention Research.

[105]  M. J. Núñez,et al.  Effects of resveratrol on expression of vascular endothelial growth factor in human gingival fibroblasts stimulated by periodontal pathogens , 2010, Acta odontologica Scandinavica.

[106]  A. Falcão,et al.  Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. , 2009, Molecular nutrition & food research.

[107]  D. Choi,et al.  Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats. , 2008, Cardiovascular therapeutics.

[108]  E. Kahn,et al.  Antiproliferative activities of resveratrol and related compounds in human hepatocyte derived HepG2 cells are associated with biochemical cell disturbance revealed by fluorescence analyses. , 2008, Biochimie.

[109]  Leonid Peshkin,et al.  Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. , 2008, Cell metabolism.

[110]  T. E. Dyke,et al.  The Management of Inflammation in Periodontal Disease , 2008 .

[111]  Z. Ovesná,et al.  Structure-activity relationship of trans-resveratrol and its analogues. , 2008, Neoplasma.

[112]  R. de Cabo,et al.  Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. , 2008, American journal of physiology. Heart and circulatory physiology.

[113]  I. Owens,et al.  Targeted inhibition of glucuronidation markedly improves drug efficacy in mice - a model. , 2007, Biochemical and biophysical research communications.

[114]  F. Halaweish,et al.  Antioxidant Effects and Drug Interactions of Resveratrol Present in Wine , 2007 .

[115]  M. Poncz,et al.  Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine , 2007, Experimental & Molecular Medicine.

[116]  J. Crowell,et al.  Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent , 2007, Cancer Epidemiology Biomarkers & Prevention.

[117]  Tristan Richard,et al.  Inhibitory activity of stilbenes on Alzheimer’s β-amyloid fibrils in vitro , 2007 .

[118]  G. Panayotou,et al.  Biological activity of acetylated phenolic compounds. , 2007, Journal of agricultural and food chemistry.

[119]  J. K. Kundu,et al.  Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. , 2006, Biochemical pharmacology.

[120]  P. Puigserver,et al.  Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.

[121]  T. Szekeres,et al.  Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells. , 2006, Experimental hematology.

[122]  R. Quirion,et al.  Specific Plasma Membrane Binding Sites for Polyphenols, Including Resveratrol, in the Rat Brain , 2006, Journal of Pharmacology and Experimental Therapeutics.

[123]  Joseph A. Baur,et al.  Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.

[124]  E. Nutescu,et al.  Warfarin and its interactions with foods, herbs and other dietary supplements , 2006, Expert opinion on drug safety.

[125]  A. Eckert,et al.  Nitric oxide alters arachidonic acid turnover in brain cortex synaptoneurosomes , 2006, Neurochemistry International.

[126]  Denis Bourgeois,et al.  The global burden of oral diseases and risks to oral health. , 2005, Bulletin of the World Health Organization.

[127]  N. Gebbia,et al.  Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. , 2005, The international journal of biochemistry & cell biology.

[128]  J. Albandar.  Epidemiology and risk factors of periodontal diseases. , 2005, Dental clinics of North America.

[129]  V. Somoza,et al.  Metabolism and bioavailability of trans-resveratrol. , 2005, Molecular nutrition & food research.

[130]  T. Szekeres,et al.  Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. , 2005, Biochemical pharmacology.

[131]  T. Walle,et al.  HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS , 2004, Drug Metabolism and Disposition.

[132]  Christian Billard,et al.  Flavones and polyphenols inhibit the NO pathway during apoptosis of leukemia B-cells. , 2004, Leukemia research.

[133]  Howard C. Tenenbaum,et al.  Inhibition of osteogenesis in vitro by a cigarette smoke-associated hydrocarbon combined with Porphyromonas gingivalis lipopolysaccharide: reversal by resveratrol. , 2004, Journal of periodontology.

[134]  J. Thénot,et al.  Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. , 2004, Biochemical and biophysical research communications.

[135]  L. Samaranayake,et al.  Topical and systemic antibiotics in the management of periodontal diseases. , 2004, International dental journal.

[136]  Poul Erik Petersen,et al.  The World Oral Health Report 2003: continuous improvement of oral health in the 21st century--the approach of the WHO Global Oral Health Programme. , 2003, Community dentistry and oral epidemiology.

[137]  Phuong Chung,et al.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.

[138]  F. Berthou,et al.  Differential inhibition of human cytochrome P450 enzymes by epsilon-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages. , 2003, Life sciences.

[139]  R. Baruchello,et al.  Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. , 2003, Journal of medicinal chemistry.

[140]  Mohammad S Al-Zahrani,et al.  Obesity and periodontal disease in young, middle-aged, and older adults. , 2003, Journal of periodontology.

[141]  J. Pezzuto,et al.  Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. , 2002, Journal of agricultural and food chemistry.

[142]  B. Wachowicz,et al.  Resveratrol and vitamin C as antioxidants in blood platelets. , 2002, Thrombosis research.

[143]  L. Hung,et al.  The protective effect of resveratrols on ischaemia‐reperfusion injuries of rat hearts is correlated with antioxidant efficacy , 2002, British journal of pharmacology.

[144]  P. Farmer,et al.  The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1 , 2002, British Journal of Cancer.

[145]  J. Stein,et al.  Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. , 2002, The Journal of nutrition.

[146]  F. Mentz,et al.  Comparative Antiproliferative and Apoptotic Effects of Resveratrol, ϵ-viniferin and Vine-shots Derived Polyphenols (Vineatrols) on Chronic B Lymphocytic Leukemia Cells and Normal Human Lymphocytes , 2002, Leukemia & lymphoma.

[147]  B. Dörken,et al.  Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts , 2001, Leukemia.

[148]  Y. Kimura,et al.  Effects of Naturally Occurring Stilbene Glucosides from Medicinal Plants and Wine, on Tumour Growth and Lung Metastasis in Lewis Lung Carcinoma‐Bearing Mice , 2000, The Journal of pharmacy and pharmacology.

[149]  Howard C. Tenenbaum,et al.  Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. , 2000, The Journal of endocrinology.

[150]  A. Pietrabissa,et al.  Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[151]  M. Iinuma,et al.  Antitumor agents 200. Cytotoxicity of naturally occurring resveratrol oligomers and their acetate derivatives. , 1999, Bioorganic & medicinal chemistry letters.

[152]  R. Lamuela-Raventós,et al.  Piceid, the major resveratrol derivative in grape juices. , 1999, Journal of agricultural and food chemistry.

[153]  L. Verotta,et al.  Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-beta-D-glucopyranoside and related compounds. , 1997, Journal of natural products.

[154]  Norman R. Farnsworth,et al.  Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.

[155]  Kimura Yoshiyuki,et al.  Effects of stilbenes on arachidonate metabolism in leukocytes. , 1985 .

[156]  Y. Kimura,et al.  Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. , 1982, Chemical & pharmaceutical bulletin.

[157]  P. Langcake,et al.  The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury , 1976 .

[158]  M. Pai,et al.  Neuroprotective effects of resveratrol in Alzheimer's disease. , 2020, Frontiers in bioscience.

[159]  R. Reiter,et al.  The effect of resveratrol on neurodegenerative disorders: possible protective actions against autophagy, apoptosis, inflammation and oxidative stress. , 2019, Current pharmaceutical design.

[160]  A. Csoka,et al.  Novel targets for parkinsonism-depression comorbidity. , 2019, Progress in molecular biology and translational science.

[161]  D. Michaud,et al.  Periodontal Disease, Tooth Loss, and Cancer Risk , 2017, Epidemiologic reviews.

[162]  P. Papapanou,et al.  Periodontal diseases , 2017, Nature Reviews Disease Primers.

[163]  E. Vesti,et al.  Alveolar bone loss associated with age-related macular degeneration in males. , 2013, Journal of periodontology.

[164]  D. Kinane,et al.  Nonsurgical mechanical treatment strategies for periodontal disease. , 2010, Dental clinics of North America.

[165]  J. Neuzil,et al.  Mitocans, a class of emerging anti-cancer drugs. , 2009, Molecular nutrition & food research.

[166]  K. Kang,et al.  Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol. , 2009, Die Pharmazie.

[167]  S. Collin,et al.  Chocolate and cocoa: New sources of trans-resveratrol and trans-piceid , 2006 .

[168]  M. Huang,et al.  Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs , 2005, Clinical pharmacokinetics.